ENHABIT INC (EHAB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:EHAB - US29332G1022 - Common Stock
9.44 USD
+0.21 (+2.28%)
9.44 USD
0 (0%)
Overall EHAB gets a fundamental rating of 4 out of 10. We evaluated EHAB against 101 industry peers in the Health Care Providers & Services industry. While EHAB is still in line with the averages on profitability rating, there are concerns on its financial health. EHAB has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year EHAB was profitable.
EHAB had a positive operating cash flow in the past year.
In multiple years EHAB reported negative net income over the last 5 years.
In the past 5 years EHAB always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -0.97%, EHAB perfoms like the industry average, outperforming 45.54% of the companies in the same industry.
EHAB has a Return On Equity (-2.10%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 4.51%, EHAB is in line with its industry, outperforming 51.49% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EHAB is significantly below the industry average of 9.21%.
The 3 year average ROIC (3.74%) for EHAB is below the current ROIC(4.51%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -2.1% | ||
| ROIC | 4.51% |
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
1.3 Margins
With a decent Operating Margin value of 5.96%, EHAB is doing good in the industry, outperforming 65.35% of the companies in the same industry.
In the last couple of years the Operating Margin of EHAB has declined.
Looking at the Gross Margin, with a value of 48.98%, EHAB is in the better half of the industry, outperforming 74.26% of the companies in the same industry.
EHAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | N/A | ||
| GM | 48.98% |
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
EHAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EHAB has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, EHAB has a worse debt to assets ratio.
2.2 Solvency
EHAB has an Altman-Z score of 1.68. This is a bad value and indicates that EHAB is not financially healthy and even has some risk of bankruptcy.
EHAB has a worse Altman-Z score (1.68) than 60.40% of its industry peers.
The Debt to FCF ratio of EHAB is 8.01, which is on the high side as it means it would take EHAB, 8.01 years of fcf income to pay off all of its debts.
EHAB's Debt to FCF ratio of 8.01 is in line compared to the rest of the industry. EHAB outperforms 54.46% of its industry peers.
EHAB has a Debt/Equity ratio of 0.78. This is a neutral value indicating EHAB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.78, EHAB perfoms like the industry average, outperforming 47.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 8.01 | ||
| Altman-Z | 1.68 |
ROIC/WACC0.47
WACC9.56%
2.3 Liquidity
EHAB has a Current Ratio of 1.58. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
EHAB has a Current ratio of 1.58. This is in the better half of the industry: EHAB outperforms 61.39% of its industry peers.
A Quick Ratio of 1.58 indicates that EHAB should not have too much problems paying its short term obligations.
EHAB's Quick ratio of 1.58 is fine compared to the rest of the industry. EHAB outperforms 64.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 |
3. Growth
3.1 Past
EHAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.30%, which is quite impressive.
EHAB shows a small growth in Revenue. In the last year, the Revenue has grown by 1.02%.
EHAB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.07% yearly.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
3.2 Future
EHAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.82% yearly.
EHAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.22% yearly.
EPS Next Y165.2%
EPS Next 2Y64.92%
EPS Next 3Y40.96%
EPS Next 5Y7.82%
Revenue Next Year2.46%
Revenue Next 2Y3.22%
Revenue Next 3Y3.54%
Revenue Next 5Y5.22%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.45, EHAB is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of EHAB indicates a somewhat cheap valuation: EHAB is cheaper than 68.32% of the companies listed in the same industry.
EHAB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.17.
The Price/Forward Earnings ratio is 16.53, which indicates a correct valuation of EHAB.
EHAB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EHAB is cheaper than 74.26% of the companies in the same industry.
EHAB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.45 | ||
| Fwd PE | 16.53 |
4.2 Price Multiples
EHAB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EHAB is cheaper than 73.27% of the companies in the same industry.
EHAB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EHAB is cheaper than 89.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.25 | ||
| EV/EBITDA | 10.06 |
4.3 Compensation for Growth
EHAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EHAB's earnings are expected to grow with 40.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y64.92%
EPS Next 3Y40.96%
5. Dividend
5.1 Amount
No dividends for EHAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
9.44
+0.21 (+2.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.3%
Inst Owner ChangeN/A
Ins Owners2.33%
Ins Owner Change8.93%
Market Cap477.76M
Revenue(TTM)1.05B
Net Income(TTM)-11.90M
Analysts76.36
Price Target9.95 (5.4%)
Short Float %3.41%
Short Ratio3.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.12%
Min EPS beat(2)23.34%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)21.77%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)6
Avg EPS beat(8)34.93%
EPS beat(12)7
Avg EPS beat(12)12.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.24%
Revenue beat(12)0
Avg Revenue beat(12)-3.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4%
PT rev (3m)4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)0%
EPS NY rev (3m)10.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.45 | ||
| Fwd PE | 16.53 | ||
| P/S | 0.46 | ||
| P/FCF | 8.25 | ||
| P/OCF | 7.67 | ||
| P/B | 0.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.06 |
EPS(TTM)0.44
EY4.66%
EPS(NY)0.57
Fwd EY6.05%
FCF(TTM)1.14
FCFY12.12%
OCF(TTM)1.23
OCFY13.04%
SpS20.7
BVpS11.2
TBVpS-7.48
PEG (NY)0.13
PEG (5Y)N/A
Graham Number10.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -2.1% | ||
| ROCE | 5.71% | ||
| ROIC | 4.51% | ||
| ROICexc | 4.76% | ||
| ROICexgc | 54.35% | ||
| OM | 5.96% | ||
| PM (TTM) | N/A | ||
| GM | 48.98% | ||
| FCFM | 5.53% |
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexgc growth 3Y-27.94%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 8.01 | ||
| Debt/EBITDA | 5.02 | ||
| Cap/Depr | 17.25% | ||
| Cap/Sales | 0.42% | ||
| Interest Coverage | 1.77 | ||
| Cash Conversion | 70.88% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 | ||
| Altman-Z | 1.68 |
F-Score7
WACC9.56%
ROIC/WACC0.47
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
EPS Next Y165.2%
EPS Next 2Y64.92%
EPS Next 3Y40.96%
EPS Next 5Y7.82%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
Revenue Next Year2.46%
Revenue Next 2Y3.22%
Revenue Next 3Y3.54%
Revenue Next 5Y5.22%
EBIT growth 1Y60.82%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year78.82%
EBIT Next 3Y23.25%
EBIT Next 5YN/A
FCF growth 1Y632.91%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y25.6%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%
ENHABIT INC / EHAB FAQ
What is the fundamental rating for EHAB stock?
ChartMill assigns a fundamental rating of 4 / 10 to EHAB.
What is the valuation status for EHAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.
Can you provide the profitability details for ENHABIT INC?
ENHABIT INC (EHAB) has a profitability rating of 4 / 10.
What is the expected EPS growth for ENHABIT INC (EHAB) stock?
The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 165.2% in the next year.